Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder AsiaPacific Fund Regulatory News (SDP)

Share Price Information for Schroder AsiaPacific Fund (SDP)

Share Price is delayed by 15 minutes
Get Live Data
838.00    -28.00 (-3.23%)
Bid:
838.00
Ask:
841.00
Spread: 3.00 (0.358%)
Market Cap: £1.06b
SDP Live PriceLast checked at - London Stock Exchange

Intraday Schroder AsiaPacific Fund Share Chart

Results analysis from Kepler Trust Intelligence

5 Jun 2026 16:40

RNS Number : 2669H
Schroder AsiaPacific Fund PLC
05 June 2026
 

Schroder AsiaPacific (SDP)

05/06/2026

Results analysis from Kepler Trust Intelligence

Schroder AsiaPacific (SDP) has released its half-year results ending 31/03/2026, delivering a NAV total return of 3.7%, a share price total return of 4.8% versus 5.2% for the trust's benchmark.

The period was marked by volatility, with the impact of the war in Iran undoing some of the strong gains achieved earlier. Despite this, the region outperformed global equities.

The standout sector was technology due to ongoing AI optimism, especially Taiwanese and Korean companies. Good stock selection here was a positive contributor to SDP, although an underweight to Korea offset some of these gains. Stock selection in Singapore and Australia also contributed positively, although China and India detracted. The impact of these latter two markets, were offset by underweight allocations, with both markets delivering negative returns in the period.

Abbas Barkhordar moved up to lead manager duties, with former co-manager Richard Sennitt becoming alternate manager. Abbas initiated five new positions, with disposals coming from changing backdrops and profit taking from good performers. China remains a key underweight allocation, albeit offset by Hong Kong. India is a notable underweight position. Abbas continues to have an overweight to technology but is zero weight in the consumer staples and utilities sectors.

The discount narrowed to 8.7% with share buybacks used to support this, with c. 6.1m shares bought back in the period, contributing 0.4% to NAV.

New Chair Nicky Richards commented on the region's appeal, which offers, "Access to a diverse set of high-quality companies across multiple markets and sectors, many of which trade at attractive valuations relative to their growth potential."

Kepler View

Newly promoted lead manager Abbas Barkhordar notes two defining features of these results: the technology sector, and Iran war disruption. On a longer-term view, the region's tech sector will likely continue to be a major driver of success due to the numerous world-leading firms being based in the region. With this in mind, Schroder AsiaPacific's (SDP) overweight continues to appeal, in our view.

Further supporting this view are the pragmatic changes made to the portfolio. Abbas has added a range of holdings, capitalising on the wide opportunity. More impressively, in our view, is the disposals made as a result of changing backdrops. Selling takes considerably more conviction, and Abbas' exits in changing backdrops demonstrate discipline.

Adding to the appeal is the current discount which has widened since publication. We believe this could offer a compelling entry point for long-term investors to access the growing economic might of the Asian region, including technology, whilst benefitting from active management.

Finally, we believe Abbas' promotion to lead manager is a natural step up and a demonstration of the strength-in-depth of Schroders. He will continue to work closely with former co-manager Richard Sennitt and the well-resourced Schroders team, which ensures further consistency of approach.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFZGGVKKNGVZM
Date   Source Headline
5th Jun 20265:13 pmRNSTransaction in Own Shares
5th Jun 20264:40 pmRNS-RResults analysis from Kepler Trust Intelligence
5th Jun 202611:36 amRNSNet Asset Value(s)
4th Jun 20265:26 pmRNSTransaction in Own Shares
4th Jun 202611:33 amRNSNet Asset Value(s)
3rd Jun 202611:17 amRNSNet Asset Value(s)
2nd Jun 20265:13 pmRNSTransaction in Own Shares
2nd Jun 202612:00 pmRNSNet Asset Value(s)
2nd Jun 20267:00 amRNSHalf-year Report
1st Jun 202611:48 amRNSNet Asset Value(s)
29th May 20265:40 pmRNSTotal Voting Rights
29th May 202611:33 amRNSNet Asset Value(s)
28th May 202611:37 amRNSNet Asset Value(s)
27th May 202611:26 amRNSNet Asset Value(s)
26th May 202611:55 amRNSNet Asset Value(s)
22nd May 20265:13 pmRNSTransaction in Own Shares
22nd May 202611:35 amRNSNet Asset Value(s)
21st May 202610:57 amRNSNet Asset Value(s)
20th May 20265:27 pmRNSTransaction in Own Shares
20th May 202611:32 amRNSNet Asset Value(s)
19th May 20265:26 pmRNSTransaction in Own Shares
19th May 202611:35 amRNSNet Asset Value(s)
18th May 20265:22 pmRNSTransaction in Own Shares
18th May 202611:36 amRNSNet Asset Value(s)
15th May 20265:16 pmRNSTransaction in Own Shares
15th May 202611:43 amRNSNet Asset Value(s)
14th May 202611:45 amRNSNet Asset Value(s)
13th May 20265:06 pmRNSTransaction in Own Shares
13th May 202611:34 amRNSNet Asset Value(s)
13th May 20267:00 amRNSDirectorate change
12th May 20265:21 pmRNSTransaction in Own Shares
12th May 20264:44 pmRNSPortfolio Update
12th May 202611:13 amRNSNet Asset Value(s)
11th May 202611:50 amRNSNet Asset Value(s)
8th May 202611:50 amRNSNet Asset Value(s)
7th May 20265:13 pmRNSTransaction in Own Shares
7th May 202611:51 amRNSNet Asset Value(s)
6th May 202611:39 amRNSNet Asset Value(s)
5th May 20265:12 pmRNSCompliance with the Market Abuse Regulation
5th May 202611:16 amRNSNet Asset Value(s)
1st May 202611:55 amRNSNet Asset Value(s)
1st May 202611:23 amRNSTotal Voting Rights
30th Apr 20265:24 pmRNSTransaction in Own Shares
30th Apr 202611:46 amRNSNet Asset Value(s)
29th Apr 20265:15 pmRNSTransaction in Own Shares
29th Apr 202610:58 amRNSNet Asset Value(s)
28th Apr 20265:02 pmRNSTransaction in Own Shares
28th Apr 202611:47 amRNSNet Asset Value(s)
27th Apr 20265:09 pmRNSTransaction in Own Shares
27th Apr 202611:17 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.